Through the preliminary RNA-seq analysis, combined with the Western blot and qRT-PCR detection of this experiment, the research team found that the prescription ZZXJD inhibited the proliferation of liver cancer cells and was related to the PI3K/Akt/m TOR and JAK2/STAT3 signaling pathways. This evidence concerns the gene AKT1 and liver cancer.